Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Homeopathy for Moderate Depression (Acute Phase)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosis of major depression by a psychiatrist,~* patients must not be currently taking antidepressants or anxiolytic drugs (with the exception of Lorazepam as rescue medication, maximal dose 1.5 mg/day)~* Capability and willingness to give informed consent and to comply with the study procedures will also be required~Exclusion Criteria:~* current mild episode of depression (HAM-D \< 17)~* current severe episode of depression (HAM-D \> 24)~* schizophrenia or other psychotic disorders~* bipolar affective disorder~* schizoaffective disorders~* alcohol or other substance abuse~* eating disorders~* a clinically significant (Diagnostic and Statistical Manual of Mental Disorders)-Axis II disorder~* severe depression, which previously motivated a suicide attempt~* a score of 4 or 5 in the Columbia-Suicide Severity Rating Scale (C-SSRS)up to three months before screening;~* a clinically significant acute or chronic disease that would hinder regular participation in the study~* treatment with antipsychotics, antidepressants, sedatives/hypnotics or mood stabilizers four weeks prior to the screening~* complementary or alternative treatment simultaneously to the study (for example, acupuncture, phytotherapy, etc.)~* homeopathic treatment eight weeks prior to study entry~* psychotherapy~* simultaneous participation in another clinical trial (the last participation in a previous clinical trial must be completed at least three months prior to screening)~* concomitant pregnancy or breastfeeding~* patients who are assumed to have a linguistic, intellectual or any other reason for not understanding the meaning of the clinical trial and for not complying with the necessary study procedures~* persons who have been institutionalized by a court order~* patients with an application for a pension

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: EXPERIMENTAL): None
- Group 2 (Type: EXPERIMENTAL): None
- Group 3 (Type: EXPERIMENTAL): None
- Group 4 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).